Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price ▲ | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Merck KGaA | 5 | 1 | 2 | 0 | €175.10 | €172.00 | -1.770% |
| Bayer AG | 19 | 3 | 7 | 2 | €28.00 | €45.00 | 60.714% |
| Evotec SE | 10 | 2 | 7 | 0 | €6.50 | €10.00 | 53.965% |
| MorphoSys AG | 7 | 0 | 0 | 0 | €67.40 | €65.00 | -3.561% |
| QIAGEN NV | 12 | 0 | 1 | 0 | €40.47 | €47.52 | 17.415% |
| AstraZeneca plc | 2 | 0 | 0 | 0 | €157.30 | €165.00 | 4.895% |
| Sanofi S.A. | 4 | 0 | 1 | 0 | €101.22 | €109.00 | 7.686% |
| Novo Nordisk A/S | 6 | 0 | 1 | 0 | €185.00 | €195.00 | 5.405% |
| Pfizer Inc. | 31 | 4 | 6 | 0 | €26.00 | €41.47 | 59.508% |
| Johnson & Johnson | 40 | 1 | 4 | 0 | €147.76 | €187.62 | 26.973% |
| Merck & Co. Inc. | 32 | 1 | 4 | 0 | €106.40 | €125.78 | 18.214% |
| Amgen Inc. | 28 | 0 | 3 | 0 | €300.45 | €304.82 | 1.454% |
| Regeneron Pharmaceuticals Inc. | 47 | 1 | 9 | 0 | €1,087.0 | €1,091.9 | 0.453% |
| Vertex Pharmaceuticals Inc. | 59 | 2 | 7 | 0 | €444.85 | €450.36 | 1.240% |
| Gilead Sciences Inc | 12 | 1 | 1 | 0 | €70.82 | €84.81 | 19.757% |
| Abbott Laboratories | 21 | 0 | 4 | 0 | €101.86 | €116.48 | 14.353% |
| Eli Lilly Corp. | 69 | 0 | 10 | 0 | €853.80 | €860.00 | 0.726% |
| Viatris Inc. | 1 | 0 | 0 | 0 | €10.65 | - | - |